Related Experiment Video
Updated: Nov 16, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Temporal trends in incidence, causes, use of mechanical circulatory support and mortality in cardiogenic shock
Benedikt Schrage1,2, Peter Moritz Becher1,2, Alina Goßling1
1Department of Cardiology, University Heart and Vascular Centre Hamburg, Martinistr. 52, Hamburg, 20246, Germany.
Insights
Cardiogenic shock incidence is rising in Germany, with changing causes and persistently high mortality. Despite advances in mechanical support, outcomes remain poor, especially for non-myocardial infarction causes.
Area of Science:
- Cardiology
- Critical Care Medicine
- Public Health
Background:
- Cardiogenic shock (CS) management is challenging, characterized by high mortality rates.
- Despite innovations, effective strategies for CS remain elusive, necessitating further research.
Purpose of the Study:
- To analyze temporal trends in CS incidence, causes, mechanical circulatory support (MCS) utilization, and mortality in Germany.
- To identify shifts in CS etiology and treatment patterns over time.
Main Methods:
- Retrospective analysis of nationwide data from German hospitals (2005-2017).
- Inclusion of 441,696 patients diagnosed with cardiogenic shock.
- Statistical analysis of incidence, causes, MCS use (IABP, ECMO, VADs), and mortality rates.
Main Results:
- CS incidence increased from 33.1 to 51.7 per 100,000 population.
- Acute myocardial infarction (AMI) remained a primary cause, but its proportion decreased.
- Use of extracorporeal membrane oxygenation (ECMO) and ventricular assist devices (VADs) significantly increased, while intra-aortic balloon pump (IABP) use declined.
- Overall mortality remained high (~60%), with slight improvement in AMI-related CS but no significant change in non-AMI CS.
Conclusions:
- CS incidence is increasing in Germany, with evolving causes and high mortality.
- Despite increased use of advanced MCS, overall mortality remains a critical concern.
- There is a pressing need for improved evidence-based strategies, particularly for CS not caused by AMI.
Aim:
The management of cardiogenic shock remains a clinical challenge even in well-developed healthcare systems, best illustrated by its high mortality despite numerous innovative proposals for management. The aim of this study was to describe temporal trends in incidence, causes, use of mechanical circulatory support, and mortality in cardiogenic shock in Germany.
Methods And Results:
Data on all cardiogenic shock patients treated in German hospitals between 2005 and 2017 were obtained from the Federal Bureau of Statistics. The data set comprised 441 696 patients with cardiogenic shock, mean age 71 (±13.8) years, 171 383 (39%) female patients. Incidence rates increased from 33.1/100 000 population in 2005 (27 246 cases) to 51.7/100 000 population in 2017 (42 779 cases). Acute myocardial infarction was the most common cause of cardiogenic shock in 2005-07 (43 422 of 82 037 cases, 52.9%), but the proportion of cases caused by it decreased until 2014-17 (73 274 of 165 873 cases, 44.2%). Over time, intra-aortic balloon pump (2005: 5104; 2017: 973 cases) was used less frequently, whereas use of extracorporeal-membrane-oxygenation (2007: 35; 2017: 2414 cases) and percutaneous left ventricular assist devices (2005: 27; 2017: 1323 cases) increased. Mortality remained high at around 60% without relevant temporal trends in patients without acute myocardial infarction and slightly decreased in patients with acute myocardial infarction.
Conclusions:
In this large, nation-wide study, annual incidence of cardiogenic shock was growing, its causes were changing, and mortality was high despite a shift towards use of novel mechanical circulatory support devices. This highlights the need to address the evidence gap in this field, in particular for cardiogenic shock caused by diseases other than acute myocardial infarction.
Related Concept Videos
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure I: Introduction
Cardiopulmonary Resuscitation IV: Pharmacological Management
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy

